AI Coal Miners? Huge if True
Weekend Flow
Notable Flow:
HCC 0.00%↑ 100C 01/17/2025 Exp
NTLA 0.00%↑ 25C 04/17/2025 Exp
AAPL 0.00%↑ 235C 12/13 Exp
CNM 0.00%↑ 45C 11/15 Exp
HCC 0.00%↑ 100C 01/17/2025 Exp
Vol: 10,433 OI: 76 Avg: $0.71 Prem: $739,043
This chain had an aggregate volume of 10.4k contracts traded on Friday, and the stock had its highest options volume in the past 90 days. Most of the volume came at 11:15 a.m. ET, with 6.2k contracts mostly traded at the Ask. Afterward, the following trades were a lot smaller, with fills at the Bid and Ask; there were 71 contracts held before this trade. The updated OI should be above 6k tomorrow, Monday, 11/11.
Warrior Met Coal Inc. reported its 2024 Q3 Earnings on 10/30. Achieving a Net Income of $41.8 million, or $0.80 per diluted share, and generating an adjusted EBITDA of $78.5 million.
Breaking out of a weekly range dating back to the tail end of 2023, HCC looks to surge through all time high’s. I have actually met a few guys from this company and obviously they had good things to say about their own operation. Located in Alabama, they have an exciting future ahead in regards to the Coal Mining operation. Trending above all moving average’s this stock has supportive momentum this stock has a good chance at running into the end of the year. Decent theme behind this as well. LONG COAL for Santa’s Naughty List.
NTLA 0.00%↑ 25C 04/17/2025 Exp
Vol: 2,641 OI: 384 Avg: $1.18 Prem: $311,824
With over 2.5k contracts traded at the Ask, the call net premium has reached its highest levels in the past 30 days. Three aggregate trades account for almost all of the daily volume on this chain.
Intellia Therapeutics reported its 2024 Q3 Earnings on 11/07, beating analysts’ estimates with an EPS of - $1.34 and revenues of $282.4k.
Investors might be bullish on NTLA into April due to several potential catalysts. The company is advancing three Phase 3 trials, including NTLA-2002 for hereditary angioedema (HAE) and two studies of NTLA-2001 (now called nexiguran ziclumeran or nex-z) for different forms of ATTR amyloidosis. Additionally, the company expects to dose the first patient in a Phase 1/2 study of NTLA-3001 for alpha-1 antitrypsin deficiency in the second half of 2024. With a strong cash position of approximately $945 million as of Q3 2024, Intellia is well-funded to advance its pipeline. The potential for positive clinical updates and progress in these trials could drive investor optimism heading into April.
Chart looks to be bottomed and ideally we can reclaim these overhead moving average’s back into 20’s.
AAPL 0.00%↑ 235C 12/13 Exp
Vol: 3,847 OI: 982 Avg: $2.36 Prem: $909,454
With 2.5k contracts traded at the Ask in a single order and $776k in premium, these OTM calls look very tempting. Apple shares gained 2.63% the last week after the election results, and the FOMC cut interest rates by 25 bps. These whales are optimistic and expect the rally to continue by adding short-term calls that expire in 35 days.
The company recently released its new iPhone 16 lineup, Apple Watch Series 10, and AirPods 4, which could drive strong holiday sales. Apple also introduced its M4 chip and Apple Intelligence features across various products, including the new iMac, MacBook Pro, and Mac mini, showcasing its commitment to AI innovation. Additionally, Apple's services revenue reached a new all-time high, indicating growth in its high-margin business segment.
The chart is still in a range trade for the last few months but is a prime candidate to surge alongside the other mega-cap companies if tech is to continue it’s breakout. AAPL is a very popular stock to not only own, but trade as well. So it is important to recognize that there is millions of dollars coming in on both sides, every day.
CNM 0.00%↑ 45C 11/15 Exp
Vol: 6,908 OI: 408 Avg: $0.63 Prem: $436,112
These whales are bullish and placing a very risky trade due to the short expiration of these calls. Based on the volume chart, it seems like they decided to hold the contracts over the weekend, if this assumption is right, OI should be around 7k tomorrow.
Core & Main recently completed two acquisitions. On 07/11, it announced the acquisition of ARGCO Northeast LLC, and on 10/31, it announced the acquisition of Eastcom Associates Inc.
The company recently reported strong third-quarter 2024 financial results, with net income of $2.2 million, marking a significant turnaround from previous losses. This positive performance demonstrates the company's ability to navigate challenging market conditions and generate profit. Additionally, Core & Main's total revenues increased substantially to $31.7 million, up from $10.8 million in the previous quarter, indicating strong growth momentum.
Although this information is fun and neat, this contract expires at the end of the week so it’s hard to materialize into short term gains unless there was to be a headline surrounding this. Certainly not the best chart in the market, but perhaps the whale knows something. Or he is financially ruined… LOL. Either way, good opportunities out there and we will do our best to find them.
That’s all for now, be on alert in case we note some more later on in the day today. Have a great day folks, take some profits!
Cheers,
Kian, Jersace, & Jon